Related Experiment Video

Updated: Aug 11, 2026

Immunization of Alpacas (Lama pacos) with Protein Antigens and Production of Antigen-specific Single Domain Antibodies
05:27

Immunization of Alpacas (Lama pacos) with Protein Antigens and Production of Antigen-specific Single Domain Antibodies

Published on: January 26, 2019

[Immuno-allergic accidents with rifamipcin]

B Flageul1, L Wagner, F Cottenot

  • 1Service de Dermatologie du Pr Dubertret, Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75475 Paris, France.

Acta Leprologica
|July 26, 2002
PubMed

Insights

Two leprosy patients experienced immuno-allergic side effects from rifampicin (RMP) treatment, including flu-like symptoms and low platelets or rash. These cases highlight RMP

Area of Science:

  • Immunology
  • Pharmacology
  • Dermatology

Background:

  • Leprosy treatment often involves multidrug therapy (MDT).
  • Rifampicin (RMP) is a key component of MDT for leprosy.
  • Immuno-allergic reactions to RMP can occur, necessitating careful monitoring.

Observation:

  • Two leprosy patients developed adverse reactions during RMP treatment.
  • Case 1: Flu-like syndrome and thrombocytopenia after restarting RMP.
  • Case 2: Flu-like syndrome and eczematous eruption after one year of RMP.

Findings:

  • Anti-RMP antibodies were detected in one patient.
  • Reactions manifested as flu syndrome, thrombocytopenia, and rash.
  • The timing and presentation of reactions varied.

Implications:

  • These cases underscore the diverse clinical spectrum of RMP-induced immuno-allergic side effects.
  • Understanding these reactions is crucial for optimizing leprosy management.
  • Further research into pathogenic mechanisms may improve patient safety.

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test08:58

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

Published on: April 30, 2019

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...